Cite
HARVARD Citation
May, C. et al. (2015). AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas. BMC cancer. 15 (1), pp. 1-12. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
May, C. et al. (2015). AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas. BMC cancer. 15 (1), pp. 1-12. [Online].